MM-202 Impact of t(11;14) in Multiple Myeloma on Response to Treatment and Survival

Borja Puertas, Eduardo Sobejano,Sandra Gómez,Alberto Hernández,Elena Alejo,David Alonso,José María Navarro, Carlos Puerta,Pablo García,Evelyn Zapata, Elena Redondo,Beatriz Rey,Norma Gutiérrez,Noemi Puig,Ramón García-Sanz,Maria Victoria Mateos,Fernando Escalante,Verónica González-Calle

Clinical Lymphoma Myeloma and Leukemia（2022）

引用 0|浏览13

暂无评分

摘要

Patients with t(11;14) did not benefit from the introduction of novel agents in terms of quality of response and survival. The t(11;14) and SR groups had similar prognoses, superior to the HR group. Within the ISS-1 group, the presence of t(11;14) was associated with worse OS.

查看译文

关键词

MM,multiple myeloma,t(11,14),cytogenetic

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要